Articles published by MeMed

New Evidence on MeMed BV’s Role in Supporting Emergency Medicine Clinical Decisions Unveiled at ACEP 2025

September 04, 2025

From MeMed

Via Business Wire

MeMed Completes Development of First-Ever Fingerstick Host-Response Test for Rapid Differentiation of Bacterial and Viral Infections

July 24, 2025

From MeMed

Via Business Wire

MeMed BV Surpasses 100,000 Patient Tests, Underscoring Adoption of Rapid Host-Response Diagnostics

June 05, 2025

From MeMed

Via Business Wire

MeMed BV Proven to Optimize Antibiotic Use, Outperform Standard Care, and Cut Costs in New Studies

February 27, 2025

From MeMed

Via Business Wire

MeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR

January 09, 2025

From MeMed

Via Business Wire

FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis

December 10, 2024

From MeMed

Via Business Wire

MeMed awarded US BARDA contract to demonstrate clinical utility of the FDA-cleared MeMed BV® test for distinguishing bacterial from viral infections

October 24, 2023

From MeMed

Via GlobeNewswire

MeMed: FDA Clears Pioneering MeMed BV Test Direct From Whole Blood Allowing Faster Time To Result And Broader Patient Access When Distinguishing Bacterial From Viral Infections

July 19, 2023

From MeMed

Via GlobeNewswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.